Interphase fluorescence in situ hybridization assay for the detection of rearrangements of the EVI-1 locus in chromosome band 3q26 in myeloid malignancies.

BACKGROUND AND OBJECTIVES Rearrangements of the EVI-1 locus in chromosome band 3q26 are associated with a poor prognosis in myeloid malignancies. To aid the diagnosis of such aberrations, and possibly disease monitoring, we established an interphase fluorescence in situ hybridization (FISH) assay for the affected breakpoint region. DESIGN AND METHODS Several overlapping PAC (P1-derived artificial chromosome) clones centromeric to the EVI-1 gene were labeled with a red fluorescent dye, and PAC clones telomeric to EVI-1 with a green fluorochrome. This dual-color probe was hybridized to cytogenetic preparations of cell lines and patients' samples, which were also investigated for the presence of 3q26 rearrangements by chromosome banding analysis. RESULTS In nuclei without 3q26 rearrangements, two pairs of co-localized red and green signals were observed, while separation of one red/green signal pair or splitting of one red or one green signal was found when 3q26 aberrations were present. The threshold value for true positivity, as determined on 20 samples from patients with myeloid malignancies without 3q26 rearrangements, was 10.2% for separation of one red/green signal pair, and 1% and 1.3% for splitting of one red or one green signal, respectively. In 17 samples from patients with a 3q26 aberration, the percentage of aberrant cells was significantly above these threshold levels. INTERPRETATION AND CONCLUSIONS We established an interphase FISH assay that efficiently identifies chromosome breakpoints affecting the EVI-1 locus in 3q26, and represents a useful complement to chromosome banding analysis for the detection of such aberrations.

[1]  R. Wieser,et al.  Interphase fluorescence in situ hybridization assay for the detection of 3q21 rearrangements in myeloid malignancies , 2001, Genes, chromosomes & cancer.

[2]  P. D. de Jong,et al.  A bacterial artificial chromosome library for sequencing the complete human genome. , 2001, Genome research.

[3]  J. Lehman,et al.  Human cell line that differentiates to all myeloid lineages and expresses neutrophil secondary granule genes. , 2000, Experimental hematology.

[4]  S. Schnittger,et al.  Mapping of leukaemia‐associated breakpoints in chromosome band 3q21 using a newly established PAC contig , 2000, British journal of haematology.

[5]  U. Jaeger,et al.  Low curative potential of bone marrow transplantation for highly aggressive acute myelogenous leukemia with inversion inv (3)(q21q26) or homologous translocation t(3;3) (q21;q26) , 2000, Annals of Hematology.

[6]  K. Suzukawa,et al.  Establishment of a novel human myeloid leukaemia cell line (HNT‐34) with t(3;3)(q21;q26), t(9;22)(q34;q11) and the expression of EVI1 gene, P210 and P190 BCR/ABL chimaeric transcripts from a patient with AML after MDS with 3q21q26 syndrome , 1997, British journal of haematology.

[7]  Y. Pekarsky,et al.  Leukemia breakpoint region in 3q21 is gene rich. , 1997, Gene.

[8]  J. Goldman,et al.  Factors influencing the false positive and negative rates of BCR‐ABL fluorescence in situ hybridization , 1997, Genes, chromosomes & cancer.

[9]  P. Marynen,et al.  Fusion of ETV6 to MDS1/EVI1 as a result of t(3;12)(q26;p13) in myeloproliferative disorders. , 1997, Cancer research.

[10]  P. Marynen,et al.  Fluorescence in situ hybridization analysis of t(3; 12)(q26; p13): a recurring chromosomal abnormality involving the TEL gene (ETV6) in myelodysplastic syndromes. , 1996, Blood.

[11]  H. Drexler,et al.  Establishment and characterization of two novel cytokine-responsive acute myeloid and monocytic leukemia cell lines, MUTZ-2 and MUTZ-3. , 1996, Leukemia.

[12]  H. Drexler,et al.  Cohabiting t(12;22) and inv(3) primary rearrangements in an acute myelomonocytic leukemia (FAB M4) cell line , 1996 .

[13]  B. Bain,et al.  Abnormalities of 3q21 and 3q26 in myeloid malignancy: a United Kingdom Cancer Cytogenetic Group study , 1995, British journal of haematology.

[14]  Y. Pekarsky,et al.  Cloning of breakpoints in 3q21 associated with hematologic malignancy. , 1995, Cancer genetics and cytogenetics.

[15]  R. Gascoyne,et al.  Acute leukemia with structural rearrangements of chromosome 3. , 1995, Leukemia & lymphoma.

[16]  J. Yokota,et al.  Identification of a breakpoint cluster region 3' of the ribophorin I gene at 3q21 associated with the transcriptional activation of the EVI1 gene in acute myelogenous leukemias with inv(3)(q21q26). , 1994, Blood.

[17]  P. Greenberg,et al.  Expression of EVI1 in myelodysplastic syndromes and other hematologic malignancies without 3q26 translocations. , 1994, Blood.

[18]  E. Thiel,et al.  Correlation of cytogenetic findings with clinical features in 18 patients with inv(3)(q21q26) or t(3;3)(q21;q26). , 1994, Leukemia.

[19]  J. Rowley,et al.  Consistent intergenic splicing and production of multiple transcripts between AML1 at 21q22 and unrelated genes at 3q26 in (3;21)(q26;q22) translocations. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[20]  J. Ihle,et al.  DNA rearrangements proximal to the EVI1 locus associated with the 3q21q26 syndrome. , 1994, Blood.

[21]  Y. Yazaki,et al.  Generation of the AML1‐EVI‐1 fusion gene in the t(3;21)(q26;q22) causes blastic crisis in chronic myelocytic leukemia. , 1994, The EMBO journal.

[22]  J. Ihle,et al.  Activation of EVI1 gene expression in human acute myelogenous leukemias by translocations spanning 300-400 kilobases on chromosome band 3q26. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[23]  R. Berger,et al.  Evi-1 expression in leukemic patients with rearrangements of the 3q25-q28 chromosomal region. , 1992, Leukemia.

[24]  J. Ihle,et al.  The Evi-1 zinc finger myeloid transforming gene is normally expressed in the kidney and in developing oocytes. , 1990, Oncogene.

[25]  C. Fonatsch,et al.  Persistent Epstein‐Barr virus infection associated with monosomy 7 or chromosome 3 abnormality in childhood myeloproliferative disorders , 1985, British journal of haematology.

[26]  P Berg,et al.  Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I. , 1977, Journal of molecular biology.

[27]  H. Drexler,et al.  Cohabiting t(12;22) and inv(3) primary rearrangements in an acute myelomonocytic leukemia (FAB M4) cell line. , 1996, Genes, chromosomes & cancer.

[28]  J. Winter,et al.  t(3;21)(q26;q22): a recurring chromosomal abnormality in therapy-related myelodysplastic syndrome and acute myeloid leukemia. , 1990, Blood.